Optinose to Present at the Needham Virtual Healthcare Conference

YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor ContactJonathan Neely[email protected]267.521.0531

Source: Optinose, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Global Capital Meets Frontier Technology at Digital Assets & Tokenization Summit in Singapore
• XRP News Today: Remittix PayFi Testing Introduces EUR and USD Transfers to Invited Holders
• Posiflex Unveils AI-Powered SCO Series Kiosk to Accelerate the Future of Self-Service Retail